Regulatory effects of costunolide on dopamine metabolism-associated genes inhibit dopamine-induced apoptosis in human dopaminergic SH-SY5Y cells

Neuroscience Letters

Volumn 507, Issue 2, 2012, Pages 101-105

  Ham, Ahrom ^a   Lee, Sung Jin ^b   Shin, Jongheon ^a   Kim, Kyung Ho ^b   Mar, Woongchon ^a  

^a Seoul National University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Synuclein; Costunolide; DAT; Dopamine; Nurr1; VMAT2

Indexed keywords

ALPHA SYNUCLEIN; COSTUNOLIDE; DOPAMINE; DOPAMINE TRANSPORTER; LIPOCORTIN 5; MESSENGER RNA; NUCLEAR RECEPTOR RELATED FACTOR 1; PROPIDIUM IODIDE; VESICULAR MONOAMINE TRANSPORTER 2;

APOPTOSIS; ARTICLE; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG INDICATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL;

APOPTOSIS; CELL LINE; DOPAMINE; DOPAMINERGIC NEURONS; GENE EXPRESSION REGULATION; HUMANS; NEUROPROTECTIVE AGENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SESQUITERPENES;

EID: 84855323710     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.10.037     Document Type: Article

References (25)

1. Cabin D.E., Shimazu K., Murphy D., Cole N.B., Gottschalk W., McIlwain K.L., Orrison B., Chen A., Ellis C.E., Paylor R., Lu B., Nussbaum R.L. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. Journal of Neuroscience 2002, 22:8797-8807.
2. Chen H.C., Chou C.K., Lee S.D., Wang J.C., Yeh S.F. Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells. Antiviral Research 1995, 27:99-109.
3. Dedov V.N., Cox G.C., Roufogalis B.D. Visualisation of mitochondria in living neurons with single- and two-photon fluorescence laser microscopy. Micron 2001, 32:653-660.
4. Eiden L.E. The vesicular neurotransmitter transporters: current perspectives and future prospects. FASEB Journal 2000, 14:2396-2400.
5. Glatt C.E., Wahner A.D., White D.J., Ruiz-Linares A., Ritz B. Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women. Human Molecular Genetics 2006, 15:299-305.
6. Guo J.T., Chen A.Q., Kong Q., Zhu H., Ma C.M., Qin C. Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells. Cellular and Molecular Neurobiology 2008, 28:35-47.
7. Ham A., Kim B., Koo U., Nam K.W., Lee S.J., Kim K.H., Shin J., Mar W. Spirafolide from bay leaf (Laurus nobilis) prevents dopamine-induced apoptosis by decreasing reactive oxygen species production in human neuroblastoma SH-SY5Y cells. Archives of Pharmacal Research 2010, 33:1953-1958.
8. Hara H., Ohta M., Adachi T. Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway. Journal of Neuroscience Research 2006, 84:860-866.
9. Kirik D., Rosenblad C., Burger C., Lundberg C., Johansen T.E., Muzyczka N., Mandel R.J., Bjorklund A. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. Journal of Neuroscience 2002, 22:2780-2791.
10. Kitamura Y., Kosaka T., Kakimura J.I., Matsuoka Y., Kohno Y., Nomura Y., Taniguchi T. Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells. Molecular Pharmacology 1998, 54:1046-1054.
11. Kobayashi H., Oikawa S., Umemura S., Hirosawa I., Kawanishi S. Mechanism of metal-mediated DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma SH-SY5Y cells. Free Radical Research 2008, 42:651-660.
12. Komiya T., Yamada Y., Moteki H., Katsuzaki H., Imai K., Hibasami H. Hot water soluble sesquiterpenes [anhydroperoxy-costunolide and 3-oxoeudesma-1,4(15),11(13)triene-12,6alpha-olide] isolated from laurel (Laurus nobilis L.) induce cell death and morphological change indicative of apoptotic chromatin condensation in leukemia cells. Oncology Reports 2004, 11:85-88.
13. Le W., Conneely O.M., He Y., Jankovic J., Appel S.H. Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury. Journal of Neurochemistry 1999, 73:2218-2221.
14. Li A., Sun A., Liu R. Preparative isolation and purification of costunolide and dehydrocostuslactone from Aucklandia lappa Decne by high-speed counter-current chromatography. Journal of Chromatography A 2005, 1076:193-197.
15. Lotharius J., Barg S., Wiekop P., Lundberg C., Raymon H.K., Brundin P. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. Journal of Biological Chemistry 2002, 277:38884-38894.
16. Merchant S.H., Gonchoroff N.J., Hutchison R.E. Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes. Cytometry 2001, 46:28-32.
17. Nicotra A., Parvez S. Apoptotic molecules and MPTP-induced cell death. Neurotoxicology and Teratology 2002, 24:599-605.
18. Park H.J., Jung W.T., Basnet P., Kadota S., Namba T. Syringin 4-O-beta-glucoside, a new phenylpropanoid glycoside, and costunolide, a nitric oxide synthase inhibitor, from the stem bark of Magnolia sieboldii. Journal of Natural Products 1996, 59:1128-1130.
19. Park S.H., Choi S.U., Lee C.O., Yoo S.E., Yoon S.K., Kim Y.K., Ryu S.Y. Costunolide a sesquiterpene from the stem bark of Magnolia sieboldii, inhibits the RAS-farnesyl-proteintransferase. Planta Medica 2001, 67:358-359.
20. Sidhu A., Wersinger C., Vernier P. Alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease. FEBS Letters 2004, 565:1-5.
21. Truong J.G., Rau K.S., Hanson G.R., Fleckenstein A.E. Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson's neurodegeneration. European Journal of Pharmacology 2003, 474:223-226.
22. Wedge D.E., Galindo J.C., Macias F.A. Fungicidal activity of natural and synthetic sesquiterpene lactone analogs. Phytochemistry 2000, 53:747-757.
23. Yang Y.X., Latchman D.S. Nurr1 transcriptionally regulates the expression of alpha-synuclein. NeuroReport 2008, 19:867-871.
24. Yu S., Ueda K., Chan P. Alpha-synuclein and dopamine metabolism. Molecular Neurobiology 2005, 31:243-254.
25. Zhao D.L., Zou L.B., Lin S., Shi J.G., Zhu H.B. Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line. Neuropharmacology 2007, 53:724-732.